343 related articles for article (PubMed ID: 38130701)
1. The role and application of vesicles in triple-negative breast cancer: Opportunities and challenges.
Wei YN; Yan CY; Zhao ML; Zhao XH
Mol Ther Oncolytics; 2023 Dec; 31():100752. PubMed ID: 38130701
[TBL] [Abstract][Full Text] [Related]
2. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Vesicles: The Landscape in the Progression, Diagnosis, and Treatment of Triple-Negative Breast Cancer.
Dong M; Liu Q; Xu Y; Zhang Q
Front Cell Dev Biol; 2022; 10():842898. PubMed ID: 35300426
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Vesicles in Triple-Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential.
Das K; Paul S; Ghosh A; Gupta S; Mukherjee T; Shankar P; Sharma A; Keshava S; Chauhan SC; Kashyap VK; Parashar D
Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835573
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles secreted by triple-negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs.
González-Callejo P; Gener P; Díaz-Riascos ZV; Conti S; Cámara-Sánchez P; Riera R; Mancilla S; García-Gabilondo M; Peg V; Arango D; Rosell A; Labernadie A; Trepat X; Albertazzi L; Schwartz S; Seras-Franzoso J; Abasolo I
Int J Cancer; 2023 May; 152(10):2153-2165. PubMed ID: 36705298
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles as a novel approach for breast cancer therapeutics.
Lee Y; Graham P; Li Y
Cancer Lett; 2023 Feb; 555():216036. PubMed ID: 36521658
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells.
Ozawa PMM; Alkhilaiwi F; Cavalli IJ; Malheiros D; de Souza Fonseca Ribeiro EM; Cavalli LR
Breast Cancer Res Treat; 2018 Dec; 172(3):713-723. PubMed ID: 30173296
[TBL] [Abstract][Full Text] [Related]
8. Applications of Extracellular Vesicles in Triple-Negative Breast Cancer.
St-Denis-Bissonnette F; Khoury R; Mediratta K; El-Sahli S; Wang L; Lavoie JR
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053616
[TBL] [Abstract][Full Text] [Related]
9. The potential role of cofilin-1 in promoting triple negative breast cancer (TNBC) metastasis via the extracellular vesicles (EVs).
Howard J; Goh CY; Gorzel KW; Higgins M; McCann A
Transl Oncol; 2022 Jan; 15(1):101247. PubMed ID: 34678587
[TBL] [Abstract][Full Text] [Related]
10. Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease.
Qattan A
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255471
[TBL] [Abstract][Full Text] [Related]
11. Photosensitive small extracellular vesicles regulate the immune microenvironment of triple negative breast cancer.
Ding YN; Ding HY; Li H; Yang R; Huang JY; Chen H; Wang LH; Wang YJ; Hu CM; An YL; Zhang ZY; Yu WP; Tang QS; Shao GL
Acta Biomater; 2023 Sep; 167():534-550. PubMed ID: 37302734
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology.
Asleh K; Dery V; Taylor C; Davey M; Djeungoue-Petga MA; Ouellette RJ
Biomark Res; 2023 Nov; 11(1):99. PubMed ID: 37978566
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Implications of the Drug Resistance Conferred by Extracellular Vesicles Derived from Triple-Negative Breast Cancer Cells.
Yi YW
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835116
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Vesicles in Breast Cancer: From Intercellular Communication to Therapeutic Opportunities.
Muttiah B; Ng SL; Lokanathan Y; Ng MH; Law JX
Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794316
[TBL] [Abstract][Full Text] [Related]
15. The roles of small extracellular vesicles as prognostic biomarkers and treatment approaches in triple-negative breast cancer.
Zhou Y; Xiao Z; Zhu W
Front Oncol; 2022; 12():998964. PubMed ID: 36212432
[TBL] [Abstract][Full Text] [Related]
16. Circulating extracellular vesicles from patients with breast cancer enhance migration and invasion via a Src‑dependent pathway in MDA‑MB‑231 breast cancer cells.
Ramírez-Ricardo J; Leal-Orta E; Martínez-Baeza E; Ortiz-Mendoza C; Breton-Mora F; Herrera-Torres A; Elizalde-Acosta I; Cortes-Reynosa P; Thompson-Bonilla R; Perez Salazar E
Mol Med Rep; 2020 Sep; 22(3):1932-1948. PubMed ID: 32582965
[TBL] [Abstract][Full Text] [Related]
17. Stem cell-derived extracellular vesicles: role in oncogenic processes, bioengineering potential, and technical challenges.
Ullah M; Qiao Y; Concepcion W; Thakor AS
Stem Cell Res Ther; 2019 Nov; 10(1):347. PubMed ID: 31771657
[TBL] [Abstract][Full Text] [Related]
18. Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges.
Wang J; Wang X; Zhang X; Shao T; Luo Y; Wang W; Han Y
Front Oncol; 2022; 12():884369. PubMed ID: 35692794
[TBL] [Abstract][Full Text] [Related]
19. The roles of extracellular vesicles in gastric cancer development, microenvironment, anti-cancer drug resistance, and therapy.
Huang T; Song C; Zheng L; Xia L; Li Y; Zhou Y
Mol Cancer; 2019 Mar; 18(1):62. PubMed ID: 30925929
[TBL] [Abstract][Full Text] [Related]
20. Proteomic Profiling of Extracellular Vesicles Released by Leptin-Treated Breast Cancer Cells: A Potential Role in Cancer Metabolism.
Gelsomino L; Barone I; Caruso A; Giordano F; Brindisi M; Morello G; Accattatis FM; Panza S; Cappello AR; Bonofiglio D; Andò S; Catalano S; Giordano C
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
